Cytoreductive Surgery During TKI Therapy May Extend Survival in EGFR-Mutated Non-Small Cell Lung Cancer Edited by Vineeta Teotia

https://www.medscape.com/viewarticle/cytoreductive-surgery-during-tki-therapy-may-extend-survival-2026a1000ks5 Surgical removal of residual tumour masses during TKI therapy was associated with improved survival in patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).